Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brad C Astor

Showing results (1-10 of 282) with videos related to

Pageof 29
Sort By:
Kidney International Reports|October 8, 2021
What is the Best Alternative for Highly Sensitized Patients Awaiting Kidney Transplantation?Brad C Astor
Nature Reviews. Nephrology|May 30, 2012
Chronic kidney disease: Estimating GFR--the right equation for the right populationBrad C Astor
Advances in Chronic Kidney Disease|July 26, 2011
Implications of proteinuria: CKD progression and cardiovascular outcomesMark J Sarnak, Brad C Astor
Journal of the American Society of Nephrology : JASN|September 10, 2011
Is there something better than the best marker of kidney function?Brad C Astor, Nrupen A Bhavsar
Clinical Journal of the American Society of Nephrology : CJASN|January 15, 2015
Alternative strategies needed to improve vascular access outcomesAlexander S Yevzlin, Brad C Astor
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 11, 2019
End-Stage Renal Disease Patients with Low Serum Albumin: Is Peritoneal Dialysis an Option?Tripti Singh, Brad C Astor, Sana Waheed
Current Opinion in Nephrology and Hypertension|March 20, 2013
Associations of endogenous markers of kidney function with outcomes: more and less than glomerular filtration rateBrad C Astor, Sumaira Shaikh, Muhammad Chaudhry
The American Journal of the Medical Sciences|November 3, 2010
Association of high-density lipoprotein cholesterol with coronary heart disease risk across categories of low-density lipoprotein cholesterol: the atherosclerosis risk in communities studyPaul Muntner, Fleur Lee, Brad C Astor
Statistics in Medicine|March 20, 2023
A comparison of two approaches to dynamic prediction: Joint modeling and landmark modelingWenhao Li, Liang Li, Brad C Astor
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 26, 2009
Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) StudyLori D Bash, Brad C Astor, Josef Coresh
Pageof 29

Showing results (1-10 of 282) with videos related to

Sort By:
Pageof 29
Kidney International Reports|October 8, 2021
What is the Best Alternative for Highly Sensitized Patients Awaiting Kidney Transplantation?Brad C Astor
Nature Reviews. Nephrology|May 30, 2012
Chronic kidney disease: Estimating GFR--the right equation for the right populationBrad C Astor
Advances in Chronic Kidney Disease|July 26, 2011
Implications of proteinuria: CKD progression and cardiovascular outcomesMark J Sarnak, Brad C Astor
Journal of the American Society of Nephrology : JASN|September 10, 2011
Is there something better than the best marker of kidney function?Brad C Astor, Nrupen A Bhavsar
Clinical Journal of the American Society of Nephrology : CJASN|January 15, 2015
Alternative strategies needed to improve vascular access outcomesAlexander S Yevzlin, Brad C Astor
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 11, 2019
End-Stage Renal Disease Patients with Low Serum Albumin: Is Peritoneal Dialysis an Option?Tripti Singh, Brad C Astor, Sana Waheed
Current Opinion in Nephrology and Hypertension|March 20, 2013
Associations of endogenous markers of kidney function with outcomes: more and less than glomerular filtration rateBrad C Astor, Sumaira Shaikh, Muhammad Chaudhry
The American Journal of the Medical Sciences|November 3, 2010
Association of high-density lipoprotein cholesterol with coronary heart disease risk across categories of low-density lipoprotein cholesterol: the atherosclerosis risk in communities studyPaul Muntner, Fleur Lee, Brad C Astor
Statistics in Medicine|March 20, 2023
A comparison of two approaches to dynamic prediction: Joint modeling and landmark modelingWenhao Li, Liang Li, Brad C Astor
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 26, 2009
Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) StudyLori D Bash, Brad C Astor, Josef Coresh
Pageof 29